Results 181 to 190 of about 342,290 (286)

Origin and Role of a Subset of Tumor-Associated Neutrophils with Antigen-Presenting Cell Features in Early-Stage Human Lung Cancer [PDF]

, 2016
Sunil Singhal, Pratik Bhojnagarwala, Shaun O’Brien, Edmund K. Moon, Alfred L. Garfall, Abhishek S. Rao, Jon G. Quatromoni, Tom L. Stephen, Leslie A. Litzky, Charuhas Deshpande, Michael D. Feldman, Wayne W. Hancock, José R. Conejo-García, Steven Μ. Albelda, Evgeniy Eruslanov   +14 more
openalex   +1 more source

Innate Immune Reprogramming Mediated by Endogenous Retroelement Dysregulation Drives Multiple Sclerosis Progression

Annals of Clinical and Translational Neurology, EarlyView.
Epigenetic reprogramming in hematopoietic stem and progenitor cells (HSPCs) and downstream myeloid cells, mediated by H3.3 downregulation and endogenous retroelement (ERE) overexpression, contributes to the progression of multiple sclerosis (MS). ABSTRACT Background Skewed myelopoiesis in the bone marrow has been identified as a key driver of multiple ...
Li‐Mei Xiao, Qiu‐Ping Zhao, Run‐Yun Li, Wei Chen, Huan‐Huan Song, Wan‐Jin Chen, Ying Fu   +6 more
wiley   +1 more source

PRDM16-dependent antigen-presenting cells induce tolerance to gut antigens. [PDF]

Nature
Fu L, Upadhyay R, Pokrovskii M, Chen FM, Romero-Meza G, Griesemer A, Littman DR.   +6 more
europepmc   +1 more source

Loss of mucosal CD1a+ dendritic (antigen presenting) cells in inflammatory bowel disease [PDF]

, 1998
SD Mann, Kamil Asaad, SC Knight, I C Talbot, MA Kamm   +4 more
openalex   +1 more source

Quantifying the Impact of Ocrelizumab on Paramagnetic Rim Lesions in Multiple Sclerosis

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Paramagnetic rim lesions (PRLs) are a subset of chronic active multiple sclerosis (MS) lesions marked by iron‐laden microglia and macrophages. Ocrelizumab, a monoclonal antibody targeting CD20+ B cells, suppresses acute MS activity, but its effect on PRLs remains unclear. In a longitudinal study of 29 ocrelizumab‐treated patients with at least
Kimberly H. Markowitz, Neha V. Safi, Iliana Pliska‐Bloch, Ulrike W. Kaunzner, Ha Luu, Yi Wang, Thanh D. Nguyen, Sandra Hurtado Rúa, Susan A. Gauthier   +8 more
wiley   +1 more source

Performance Characteristics of Anti–Collagen II Antibodies in Relapsing Polychondritis and Related Diseases: Prospective Analysis, Systematic Review, and Meta‐Analysis

Arthritis Care &Research, EarlyView.
Objective Relapsing polychondritis (RP) is a rare disease defined by recurrent cartilaginous inflammation. Anti–collagen II (Col2) antibodies have been proposed as a diagnostic biomarker for RP, but their performance characteristics are not well defined.
Karyssa Stonick, Marcela A. Ferrada, Alice Fike, Kaitlin A. Quinn, Benjamin A. Turturice, Casey Stein, Peter C Grayson   +6 more
wiley   +1 more source

Editorial: A Living History of Immunology

Frontiers in Immunology, 2015
Kendall Arthur Smith
doaj   +1 more source

Targeting Antigen-Presenting Cells to Enhance the Tumor-Spleen Immunity Cycle through Liposome-Neoantigen Vaccine. [PDF]

Adv Sci (Weinh)
Xu Y, Wang B, Huang Y, Liao J, Wu C, Zhou C, Kang Z, Jiang S, Wu BC, Zhang D, Xu R, Liu X, Wang F.   +12 more
europepmc   +1 more source

Distinctive CD8+ T cell activation by antigen-presenting plasmacytoid dendritic cells compared to conventional dendritic cells

Renée M. van der Sluis, Juan L. García‐Rodríguez, Ian Helstrup Nielsen, Albert Gris‐Oliver, Stephan Becker, Bibiana Costa, M. Zeeshan Chaudhry, Marvin Werner, Anders Laustsen, Jesper G Pedersen, Kristine Raaby Gammelgaard, Trine H. Mogensen, Ulrich Kalinke, Luka Čičin‐Šain, Rasmus O. Bak, Lasse S. Kristensen, Martin R. Jakobsen   +16 more
openalex   +2 more sources

Dendritic Cell Vaccines Presenting Autologous Tumor Antigens from Self-renewing Cancer Cells in Metastatic Renal Cell Carcinoma [PDF]

, 2018
Robert O. Dillman, Carol DePriest
openalex   +1 more source